The role of tenascin-C in tissue injury and tumorigenesis

Journal of Cell Communication and Signaling

Volumn 3, Issue 3-4, 2009, Pages 287-310

  Midwood, Kim S ^a   Orend, Gertraud ^b,c,d  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b INSERM   (France)

^c UNIVERSITÉ DE STRASBOURG   (France)

^d UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

Angiogenesis; Arthritis; Cancer; Cytokine; Extracellular matrix; Fibronectin; Inflammation; Oncogene; Signaling; Tenascin C; Tumor; Wound healing

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CD3 ANTIGEN; DICKKOPF 1 PROTEIN; ENDOTHELIN RECEPTOR; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; FIBRONECTIN; INTERLEUKIN 6; INTERLEUKIN 8; LIPOCORTIN 2; MATRIX METALLOPROTEINASE; PERLECAN; PLATELET DERIVED GROWTH FACTOR; SCATTER FACTOR RECEPTOR; SYNDECAN 4; TENASCIN; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN A; VERY LATE ACTIVATION ANTIGEN 5; WNT PROTEIN;

ADAPTIVE IMMUNITY; ANGIOGENESIS; ASTHMA; CANCER GROWTH; CARCINOGENESIS; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; EPITHELIZATION; EXTRACELLULAR MATRIX; FIBROBLAST; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE INTERACTION; GENE STRUCTURE; GENE TARGETING; HUMAN; IMMUNOPATHOGENESIS; INFLAMMATION; INFLAMMATORY INFILTRATE; INNATE IMMUNITY; KERATINOCYTE; LIGAND BINDING; LYMPHOCYTIC INFILTRATION; METASTASIS; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; SKIN INJURY; T LYMPHOCYTE ACTIVATION; TISSUE INJURY; TISSUE REPAIR; UPREGULATION; WOUND HEALING;

EID: 72449127497     PISSN: 18739601     EISSN: 1873961X     Source Type: Journal    
DOI: 10.1007/s12079-009-0075-1     Document Type: Review

References (244)

1. M Adams JL Jones RA Walker JH Pringle SC Bell 2002 Changes in tenascin-C isoform expression in invasive and preinvasive breast disease Cancer Res 62 3289 3297 12036947
2. A Aicher O Kollet C Heeschen S Liebner C Urbich C Ihling A Orlandi T Lapidot AM Zeiher S Dimmeler 2008 The Wnt antagonist Dickkopf-1 mobilizes vasculogenic progenitor cells via activation of the bone marrow endosteal stem cell niche Circ Res 103 796 803 18776043
3. G Akabani DA Reardon RE Coleman TZ Wong SD Metzler JE Bowsher DP Barboriak JM Provenzale KL Greer D DeLong HS Friedman AH Friedman XG Zhao CN Pegram RE McLendon DD Bigner MR Zalutsky 2005 Dosimetry and radiographic analysis of 131I-labeled anti-tenascin 81C6 murine monoclonal antibody in newly diagnosed patients with malignant gliomas: a phase II study J Nucl Med. 46 1042 1051 15937318
4. AN Alexopoulou HA Multhaupt JR Couchman 2007 Syndecans in wound healing, inflammation and vascular biology Int J Biochem Cell Biol 39 505 528 17097330
5. K Amin A Ekberg-Jansson CG Lofdahl P Venge 2003 Relationship between inflammatory cells and structural changes in the lungs of asymptomatic and never smokers: a biopsy study Thorax 58 135 142 12554896
6. K Amin D Ludviksdottir C Janson O Nettelbladt E Bjornsson GM Roomans G Boman L Seveus P Venge 2000 Inflammation and structural changes in the airways of patients with atopic and nonatopic asthma BHR Group Am J Respir Crit Care Med 162 2295 2301 11112154
7. I Aukhil P Joshi Y Yan HP Erickson 1993 Cell- and heparin-binding domains of the hexabrachion arm identified by tenascin expression proteins J Biol Chem. 268 2542 2553 7679097
8. F Balkwill KA Charles A Mantovani 2005 Smoldering and polarized inflammation in the initiation and promotion of malignant disease Cancer Cell. 7 211 217 15766659
9. Ballard VL, Sharma A, Duignan I, Holm JM, Chin A, Choi R, Hajjar KA, Wong SC, Edelberg JM (2006) Vascular tenascin-C regulates cardiac endothelial phenotype and neovascularization. Faseb J. 20:717-719
10. K Beiter E Hiendlmeyer T Brabletz F Hlubek A Haynl C Knoll T Kirchner A Jung 2005 beta-Catenin regulates the expression of tenascin-C in human colorectal tumors Oncogene. 24 8200 8204 16091738
11. SC Bell JH Pringle DJ Taylor TM Malak 1999 Alternatively spliced tenascin-C mRNA isoforms in human fetal membranes Mol Hum Reprod. 5 1066 1076 10541570
12. A Ben-Baruch 2006 Inflammation-associated immune suppression in cancer: the roles played by cytokines, chemokines and additional mediators Semin Cancer Biol 16 38 52 16139507
13. P Betz A Nerlich J Tubel R Penning W Eisenmenger 1993 Localization of tenascin in human skin wounds-an immunohistochemical study Int J Legal Med 105 325 328 7686039 (Pubitemid 23156594)
14. MJ Bissell MA Labarge 2005 Context tissue plasticity, and cancer: are tumor stem cells also regulated by the microenvironment? Cancer Cell. 7 17 23 15652746
15. MJ Bissell D Radisky 2001 Putting tumours in context Nat Rev Cancer. 1 46 54 11900251
16. L Borsi G Allemanni B Gaggero L Zardi 1996 Extracellular pH controls pre-mRNA alternative splicing of tenascin-C in normal, but not in malignantly transformed, cells Int J Cancer 66 632 635 8647625
17. L Borsi E Balza P Castellani B Carnemolla M Ponassi G Querze L Zardi 1994 Cell-cycle dependent alternative splicing of the tenascin primary transcript Cell Adhes Commun 1 307 317 7521758
18. Boyd NL, Martin S, Chavez A, Gunasekara A, Salleh O, Melnichouk M, Yaffe C, Friedenreich S, Minkin, Bronskill M (2009) Breast-tissue composition and other risk factors for breast cancer in young women: a cross-sectional study. Lancet Oncol 10:569-580
19. WW Busse RF Lemanske Jr 2001 Asthma N Engl J Med. 344 350 362 11172168
20. Calvo A, Catena R, Noble MS, Carbott D, Gil-Bazo I, Gonzalez-Moreno O, Huh JI, Sharp R, Qiu TH, Anver MR, Merlino G, Dickson RB, Johnson MD, Green JE (2008) Identification of VEGF-regulated genes associated with increased lung metastatic potential: functional involvement of tenascin-C in tumor growth and lung metastasis. Oncogene 27:5373-5386
21. AE Canfield AM Schor 1995 Evidence that tenascin and thrombospondin-1 modulate sprouting of endothelial cells J Cell Sci. 108 Pt 2 797 809 7539439
22. P Carmeliet 2000 Mechanisms of angiogenesis and arteriogenesis Nat Med 6 389 395 10742145
23. B Carnemolla P Castellani M Ponassi L Borsi S Urbini G Nicolo A Dorcaratto G Viale G Winter D Neri L Zardi 1999 Identification of a glioblastoma-associated tenascin-C isoform by a high affinity recombinant antibody Am J Pathol 154 1345 1352 10329587
24. R Castellon S Caballero HK Hamdi SR Atilano AM Aoki RW Tarnuzzer MC Kenney MB Grant AV Ljubimov 2002 Effects of tenascin-C on normal and diabetic retinal endothelial cells in culture Invest Ophthalmol Vis Sci 43 2758 2766 12147613 (Pubitemid 34809470)
25. N Cella R Chiquet-Ehrismann NE Hynes 2000 Lactogenic hormones and tenascin-C regulate C/EBPalpha and beta in mammary epithelial cells J Cell Biochem. 76 394 403 10649437
26. M Chiquet DM Fambrough 1984 Chick myotendinous antigen I. A monoclonal antibody as a marker for tendon and muscle morphogenesis J Cell Biol. 98 1926 1936 6725406
27. M Chiquet L Gelman R Lutz S Maier 2009 From mechanotransduction to extracellular matrix gene expression in fibroblasts Biochim Biophys Acta 1793 911 920 19339214
28. R Chiquet-Ehrismann 2004 Tenascins Int J Biochem Cell Biol 36 986 990 15094113
29. R Chiquet-Ehrismann M Chiquet 2003 Tenascins: regulation and putative functions during pathological stress J Pathol. 200 488 499 12845616
30. R Chiquet-Ehrismann C Hagios K Matsumoto 1994 The tenascin gene family Perspect Dev Neurobiol 2 3 7 7530141
31. R Chiquet-Ehrismann EJ Mackie CA Pearson T Sakakura 1986 Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis Cell 47 131 139 2428505
32. R Chiquet-Ehrismann Y Matsuoka U Hofer J Spring C Bernasconi M Chiquet 1991 Tenascin variants: differential binding to fibronectin and distinct distribution in cell cultures and tissues Cell Regul. 2 927 938 1725601
33. CY Chung HP Erickson 1994 Cell surface annexin II is a high affinity receptor for the alternatively spliced segment of tenascin-C J Cell Biol. 126 539 548 7518469
34. CY Chung HP Erickson 1997 Glycosaminoglycans modulate fibronectin matrix assembly and are essential for matrix incorporation of tenascin-C J Cell Sci. 110 1413 1419 9217327
35. CY Chung JE Murphy-Ullrich HP Erickson 1996 Mitogenesis, cell migration, and loss of focal adhesions induced by tenascin-C interacting with its cell surface receptor, annexin II Mol Biol Cell 7 883 892 8816995
36. CY Chung L Zardi HP Erickson 1995 Binding of tenascin-C to soluble fibronectin and matrix fibrils J Biol Chem. 270 29012 29017 7499434
37. RA Clark 1993 Biology of dermal wound repair Dermatol Clin 11 647 666 8222349
38. RA Clark HP Erickson TA Springer 1997 Tenascin supports lymphocyte rolling J Cell Biol. 137 755 765 9151679
39. ED Cohen K Ihida-Stansbury MM Lu RA Panettieri PL Jones EE Morrisey 2009 Wnt signaling regulates smooth muscle precursor development in the mouse lung via a tenascin C/PDGFR pathway J Clin Invest. 119 2538 2549 19690384
40. LM Coussens Z Werb 2002 Inflammation and cancer Nature 420 860 867 12490959
41. KN Cowan PL Jones M Rabinovitch 2000 Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease J Clin Invest. 105 21 34 10619858
42. KL Crossin 1991 Cytotactin binding: inhibition of stimulated proliferation and intracellular alkalinization in fibroblasts Proc Natl Acad Sci U S A. 88 11403 11407 1722330
43. JM Day AI Olin AD Murdoch A Canfield T Sasaki R Timpl TE Hardingham A Aspberg 2004 Alternative splicing in the aggrecan G3 domain influences binding interactions with tenascin-C and other extracellular matrix proteins J Biol Chem. 279 12511 12518 14722076
44. O De Wever QD Nguyen L Van Hoorde M Bracke E Bruyneel C Gespach M Mareel 2004 Tenascin-C and SF/HGF produced by myofibroblasts in vitro provide convergent pro-invasive signals to human colon cancer cells through RhoA and Rac Faseb J. 18 1016 1018 15059978
45. M Degen F Brellier R Kain C Ruiz L Terracciano G Orend R Chiquet-Ehrismann 2007 Tenascin-W is a novel marker for activated tumor stroma in low-grade human breast cancer and influences cell behavior Cancer Res 67 9169 9179 17909022
46. M Degen F Brellier S Schenk R Driscoll K Zaman R Stupp L Tornillo L Terracciano R Chiquet-Ehrismann C Ruegg W Seelentag 2008 Tenascin-W, a new marker of cancer stroma, is elevated in sera of colon and breast cancer patients Int J Cancer 122 2454 2461 18306355
47. S Denda U Müller KL Crossin HP Erickson LF Reichardt 1998 Utilization of a soluble integrin-alkaline phosphatase chimera to characterize integrin alpha 8 beta 1 receptor interactions with tenascin: murine alpha 8 beta 1 binds to the RGD site in tenascin-C fragments, but not to native tenascin-C Biochemistry 37 5464 5474 9548928
48. LB Derr R Chiquet-Ehrismann R Gandour-Edwards J Spence RP Tucker 1997 The expression of tenascin-C with the AD1 variable repeat in embryonic tissues, cell lines and tumors in various vertebrate species Differentiation. 62 71 82 9404002
49. TA DiMeo K Anderson P Phadke C Feng CM Perou S Naber C Kuperwasser 2009 A novel lung metastasis signature links Wnt signaling with cancer cell self-renewal and epithelial-mesenchymal transition in basal-like breast cancer Cancer Res 69 5364 5373 19549913
50. MA Dobrovolskaia SV Kozlov 2005 Inflammation and cancer: when NF-kappaB amalgamates the perilous partnership Curr Cancer Drug Targets. 5 325 344 16101381
51. M Drumea-Mirancea JT Wessels CA Muller M Essl JA Eble E Tolosa M Koch DP Reinhardt M Sixt L Sorokin YD Stierhof H Schwarz G Klein 2006 Characterization of a conduit system containing laminin-5 in the human thymus: a potential transport system for small molecules J Cell Sci. 119 1396 1405 16537647
52. M Dueck S Riedl U Hinz A Tandara P Moller C Herfarth A Faissner 1999 Detection of tenascin-C isoforms in colorectal mucosa, ulcerative colitis, carcinomas and liver metastases Int J Cancer 82 477 483 10404058
53. A El-Karef T Yoshida EC Gabazza T Nishioka H Inada T Sakakura K Imanaka-Yoshida 2007 Deficiency of tenascin-C attenuates liver fibrosis in immune-mediated chronic hepatitis in mice J Pathol. 211 86 94 17121418
54. P End G Panayotou A Entwistle MD Waterfield M Chiquet 1992 Tenascin: a modulator of cell growth Eur J Biochem 209 1041 1051 1385122
55. A Faissner 1997 The tenascin gene family in axon growth and guidance Cell Tissue Res 290 331 341 9321695
56. A Faissner J Kruse K Kuhn M Schachner 1990 Binding of the J1 adhesion molecules to extracellular matrix constituents J Neurochem. 54 1004 1015 2303805
57. R Fassler T Sasaki R Timpl ML Chu S Werner 1996 Differential regulation of fibulin, tenascin-C, and nidogen expression during wound healing of normal and glucocorticoid-treated mice Exp Cell Res 222 111 116 8549652 (Pubitemid 26046577)
58. W Filsell S Rudman G Jenkins MR Green 1999 Coordinate upregulation of tenascin C expression with degree of photodamage in human skin Br J Dermatol 140 592 599 10233307
59. D Fischer R Chiquet-Ehrismann C Bernasconi M Chiquet 1995 A single heparin binding region within the fibrinogen-like domain is functional in chick tenascin-C J Biol Chem. 270 3378 3384 7531705
60. D Fischer RP Tucker R Chiquet-Ehrismann JC Adams 1997 Cell-adhesive responses to tenascin-C splice variants involve formation of fascin microspikes Mol Biol Cell 8 2055 2075 9348542
61. JW Fischer 2007 Tenascin-C: a key molecule in graft stenosis Cardiovasc Res 74 335 336 17459357
62. M Fluck SI Mund JC Schittny S Klossner AC Durieux MN Giraud 2008 Mechano-regulated tenascin-C orchestrates muscle repair Proc Natl Acad Sci U S A. 105 13662 13667 18757758
63. E Forsberg E Hirsch L Frohlich M Meyer P Ekblom A Aszodi S Werner R Fassler 1996 Skin wounds and severed nerves heal normally in mice lacking tenascin-C Proc Natl Acad Sci U S A. 93 6594 6599 8692862
64. K Fujinaga K Onoda K Yamamoto K Imanaka-Yoshida M Takao T Shimono H Shimpo T Yoshida I Yada 2004 Locally applied cilostazol suppresses neointimal hyperplasia by inhibiting tenascin-C synthesis and smooth muscle cell proliferation in free artery grafts J Thorac Cardiovasc Surg. 128 357 363 15354092
65. C Gaggioli S Hooper C Hidalgo-Carcedo R Grosse JF Marshall K Harrington E Sahai 2007 Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells Nat Cell Biol 9 1392 1400 18037882
66. K Geboes MY El-Zine I Dalle S El-Haddad P Rutgeerts P Van Eyken 2001 Tenascin and strictures in inflammatory bowel disease: an immunohistochemical study Int J Surg Pathol. 9 281 286 12574843 (Pubitemid 34031142)
67. C Geffrotin Y Tricaud F Crechet M Castelli JL Lefaix M Vaiman 1998 Unlike tenascin-X, tenascin-C is highly up-regulated in pig cutaneous and underlying muscle tissue developing fibrosis after necrosis induced by very high-dose gamma radiation Radiat Res 149 472 481 9588358
68. MJ Gerritsen ME Elbers EM de Jong PC van de Kerkhof 1997 Recruitment of cycling epidermal cells and expression of filaggrin, involucrin and tenascin in the margin of the active psoriatic plaque, in the uninvolved skin of psoriatic patients and in the normal healthy skin J Dermatol Sci. 14 179 188 9138475
69. A Ghatnekar M Trojanowska 2008 GATA-6 is a novel transcriptional repressor of the human Tenascin-C gene expression in fibroblasts Biochim Biophys Acta 1779 145 151 18177748
70. R Gherzi B Carnemolla A Siri M Ponassi E Balza L Zardi 1995 Human tenascin gene. Structure of the 5-region, identification, and characterization of the transcription regulatory sequences J Biol Chem 270 3429 3434 7531707
71. A Giese MA Loo SA Norman S Treasurywala ME Berens 1996 Contrasting migratory response of astrocytoma cells to tenascin mediated by different integrins J Cell Sci. 109 Pt 8 2161 2168 8856512
72. D Gindre S Peyrol M Raccurt P Sommer R Loire JA Grimaud JF Cordier 1995 Fibrosing vasculitis in Wegener's granulomatosis: ultrastructural and immunohistochemical analysis of the vascular lesions Virchows Arch 427 385 393 8548123
73. SJ Goodger CJ Robinson KJ Murphy N Gasiunas NJ Harmer TL Blundell DA Pye JT Gallagher 2008 Evidence that heparin saccharides promote FGF2 mitogenesis through two distinct mechanisms J Biol Chem. 283 13001 13008 18281281
74. S Gordon 2002 Pattern recognition receptors: doubling up for the innate immune response Cell 111 927 930 12507420
75. M Gotz J Bolz A Joester A Faissner 1997 Tenascin-C synthesis and influence on axonal growth during rat cortical development Eur J NeuroSci 9 496 506 9104592
76. RA Hancox MD Allen DL Holliday DR Edwards CJ Pennington DS Guttery JA Shaw RA Walker JH Pringle JL Jones 2009 Tumor-associated tenascin-C isoforms promote breast cancer cell invasion and growth by matrix metalloproteinase- dependent and independent mechanisms Breast Cancer Res 11 R24 19405959
77. JH Harmey CD Bucana W Lu AM Byrne S McDonnell C Lynch D Bouchier-Hayes Z Dong 2002 Lipopolysaccharide-induced metastatic growth is associated with increased angiogenesis, vascular permeability and tumor cell invasion Int J Cancer 101 415 422 12216068
78. D Hauzenberger P Olivier D Gundersen C Ruegg 1999 Tenascin-C inhibits beta1 integrin-dependent T lymphocyte adhesion to fibronectin through the binding of its fnIII 1-5 repeats to fibronectin Eur J Immunol 29 1435 1447 10359097
79. U Hedin J Holm GK Hansson 1991 Induction of tenascin in rat arterial injury Relationship to altered smooth muscle cell phenotype Am J Pathol 139 649 656 1716048
80. J Helleman MP Jansen K Ruigrok-Ritstier IL van Staveren MP Look ME Meijer-van Gelder AM Sieuwerts JG Klijn S Sleijfer JA Foekens EM Berns 2008 Association of an extracellular matrix gene cluster with breast cancer prognosis and endocrine therapy response Clin Cancer Res. 14 5555 5564 18765548
81. TJ Hemesath LS Marton K Stefansson 1994 Inhibition of T cell activation by the extracellular matrix protein tenascin J Immunol. 152 5199 5207 7514630
82. MJ Hendrix EA Seftor AR Hess RE Seftor 2003 Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma Nat Rev Cancer. 3 411 421 12778131
83. C Herold-Mende MM Mueller MM Bonsanto HP Schmitt S Kunze HH Steiner 2002 Clinical impact and functional aspects of tenascin-C expression during glioma progression Int J Cancer 98 362 369 11920587
84. T Herrmann L Grosse-Hovest T Otz PH Krammer HG Rammensee G Jung 2008 Construction of optimized bispecific antibodies for selective activation of the death receptor CD95 Cancer Res 68 1221 1227 18281499
85. S Hibino K Kato S Kudoh H Yagita K Okumura 1998 Tenascin suppresses CD3-mediated T cell activation Biochem Biophys Res Commun 250 119 124 9735343
86. BJ Hicke AW Stephens T Gould YF Chang CK Lynott J Heil S Borkowski CS Hilger G Cook S Warren PG Schmidt 2006 Tumor targeting by an aptamer J Nucl Med. 47 668 678 16595502
87. W Huang R Chiquet-Ehrismann JV Moyano A Garcia-Pardo G Orend 2001 Interference of tenascin-C with syndecan-4 binding to fibronectin blocks cell adhesion and stimulates tumor cell proliferation Cancer Res 61 8586 8594 11731446
88. SP Hussain LJ Hofseth CC Harris 2003 Radical causes of cancer Nat Rev Cancer. 3 276 285 12671666
89. K Imai M Kusakabe T Sakakura I Nakanishi Y Okada 1994 Susceptibility of tenascin to degradation by matrix metalloproteinases and serine proteinases FEBS Lett 352 216 218 7523186
90. DE Ingber 2002 Mechanical signaling and the cellular response to extracellular matrix in angiogenesis and cardiovascular physiology Circ Res 91 877 887 12433832
91. KC Ingham SA Brew HP Erickson 2004 Localization of a cryptic binding site for tenascin on fibronectin J Biol Chem. 279 28132 28135 15123658
92. K Ishii K Imanaka-Yoshida T Yoshida Y Sugimura 2008 Role of stromal tenascin-C in mouse prostatic development and epithelial cell differentiation Dev Biol 324 310 319 18950615
93. F Ishikawa K Nose M Shibanuma 2008 Downregulation of hepatocyte nuclear factor-4alpha and its role in regulation of gene expression by TGF-beta in mammary epithelial cells Exp Cell Res 314 2131 2140 18433744
94. P Iyengar TP Combs SJ Shah V Gouon-Evans JW Pollard C Albanese L Flanagan MP Tenniswood C Guha MP Lisanti RG Pestell PE Scherer 2003 Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and proto-oncogene stabilization Oncogene. 22 6408 6423 14508521
95. AK Iyer KT Tran CW Borysenko M Cascio CJ Camacho HC Blair I Bahar A Wells 2007 Tenascin cytotactin epidermal growth factor-like repeat binds epidermal growth factor receptor with low affinity J Cell Physiol. 211 748 758 17311283
96. AK Iyer KT Tran L Griffith A Wells 2008 Cell surface restriction of EGFR by a tenascin cytotactin-encoded EGF-like repeat is preferential for motility-related signaling J Cell Physiol. 214 504 512 17708541
97. GI Jallo DR Friedlander PJ Kelly JH Wisoff M Grumet D Zagzag 1997 Tenascin-C expression in the cyst wall and fluid of human brain tumors correlates with angiogenesis Neurosurgery. 41 1052 1059 9361058
98. A Joester A Faissner 2001 The structure and function of tenascins in the nervous system Matrix Biol 20 13 22 11246000
99. FS Jones S Hoffman BA Cunningham GM Edelman 1989 A detailed structural model of cytotactin: protein homologies, alternative RNA splicing, and binding regions Proc Natl Acad Sci U S A. 86 1905 1909 2467292
100. PL Jones N Boudreau CA Myers HP Erickson MJ Bissell 1995 Tenascin-C inhibits extracellular matrix-dependent gene expression in mammary epithelial cells Localization of active regions using recombinant tenascin fragments J Cell Sci. 108 Pt 2 519 527 7539436
101. PL Jones J Crack M Rabinovitch 1997 Regulation of tenascin-C, a vascular smooth muscle cell survival factor that interacts with the alpha v beta 3 integrin to promote epidermal growth factor receptor phosphorylation and growth J Cell Biol. 139 279 293 9314546
102. PL Jones FS Jones 2000 Tenascin-C in development and disease: gene regulation and cell function Matrix Biol 19 581 596 11102748
103. J Julian R Chiquet-Ehrismann HP Erickson DD Carson 1994 Tenascin is induced at implantation sites in the mouse uterus and interferes with epithelial cell adhesion Development. 120 661 671 7512897
104. E Kaariainen P Nummela J Soikkeli M Yin M Lukk T Jahkola S Virolainen A Ora E Ukkonen O Saksela E Holtta 2006 Switch to an invasive growth phase in melanoma is associated with tenascin-C, fibronectin, and procollagen-I forming specific channel structures for invasion J Pathol. 210 181 191 16924594
105. R Kaarteenaho-Wiik E Lakari Y Soini R Pollanen VL Kinnula P Paakko 2000 Tenascin expression and distribution in pleural inflammatory and fibrotic diseases J Histochem Cytochem. 48 1257 1268 10950882
106. R Kaarteenaho-Wiik P Mertaniemi E Sajanti Y Soini P Paakko 1998 Tenascin is increased in epithelial lining fluid in fibrotic lung disorders Lung 176 371 380 9780295
107. I Kalembeyi H Inada R Nishiura K Imanaka-Yoshida T Sakakura T Yoshida 2003 Tenascin-C upregulates matrix metalloproteinase-9 in breast cancer cells: direct and synergistic effects with transforming growth factor beta1 Int J Cancer 105 53 60 12672030
108. M Kanayama D Kurotaki J Morimoto T Asano Y Matsui Y Nakayama Y Saito K Ito C Kimura N Iwasaki K Suzuki T Harada HM Li J Uehara T Miyazaki A Minami S Kon T Uede 2009 Alpha9 integrin and its ligands constitute critical joint microenvironments for development of autoimmune arthritis J Immunol. 182 8015 8025 19494327
109. A Kaplony DR Zimmermann RW Fischer BA Imhof BF Odermatt KH Winterhalter L Vaughan 1991 Tenascin Mr 220, 000 isoform expression correlates with corneal cell migration Development. 112 605 614 1724418
110. M Karin FR Greten 2005 NF-kappaB: linking inflammation and immunity to cancer development and progression Nat Rev Immunol. 5 749 759 16175180
111. EM Karjalainen A Laitinen M Sue-Chu A Altraja L Bjermer LA Laitinen 2000 Evidence of airway inflammation and remodeling in ski athletes with and without bronchial hyperresponsiveness to methacholine Am J Respir Crit Care Med 161 2086 2091 10852791
112. M Kaspar L Zardi D Neri 2006 Fibronectin as target for tumor therapy Int J Cancer 118 1331 1339 16381025
113. S Katz M Hukkanen K Lounatmaa P Rousselle T Tervo I Virtanen 2006 Cooperation of isoforms of laminin-332 and tenascin-CL during early adhesion and spreading of immortalized human corneal epithelial cells Exp Eye Res 83 1412 1422 16963023
114. K Kenji U Hironori Y Hideya I Michinori H Yasuhiko K Nobuoki 2004 Tenascin-C is associated with coronary plaque instability in patients with acute coronary syndromes Circ J. 68 198 203 14993772
115. S Kim H Takahashi WW Lin P Descargues S Grivennikov Y Kim JL Luo M Karin 2009 Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis Nature 457 102 106 19122641
116. HE Knaggs AM Layton C Morris EJ Wood DB Holland WJ Cunliffe 1994 Investigation of the expression of the extracellular matrix glycoproteins tenascin and fibronectin during acne vulgaris Br J Dermatol 130 576 582 7515637
117. Konstantopoulos K, Thomas SN (2009) Cancer Cells in Transit: The Vascular Interactions of Tumor Cells. Annu Rev Biomed Eng 11:177-202
118. Y Koyama M Kusubata A Yoshiki N Hiraiwa T Ohashi S Irie M Kusakabe 1998 Effect of tenascin-C deficiency on chemically induced dermatitis in the mouse J Invest Dermatol. 111 930 935 9856798
119. T Kucera B Strilic K Regener M Schubert V Laudet E Lammert 2009 Ancestral vascular lumen formation via basal cell surfaces PLoS ONE 4 e4132 19125185
120. C Kuhn RJ Mason 1995 Immunolocalization of SPARC, tenascin, and thrombospondin in pulmonary fibrosis Am J Pathol 147 1759 1769 7495300
121. M Kusubata A Hirota T Ebihara K Kuwaba Y Matsubara T Sasaki M Kusakabe T Tsukada S Irie Y Koyama 1999 Spatiotemporal changes of fibronectin, tenascin-C, fibulin-1, and fibulin-2 in the skin during the development of chronic contact dermatitis J Invest Dermatol. 113 906 912 10594729
122. SA Kuznetsova DD Roberts 2004 Functional regulation of T lymphocytes by modulatory extracellular matrix proteins Int J Biochem Cell Biol 36 1126 1134 15094127
123. K Lange M Kammerer ME Hegi S Grotegut A Dittmann W Huang E Fluri GW Yip M Gotte C Ruiz G Orend 2007 Endothelin receptor type B counteracts tenascin-C-induced endothelin receptor type A-dependent focal adhesion and actin stress fiber disorganization Cancer Res 67 6163 6173 17616673
124. K Lange M Kammerer F Saupe ME Hegi S Grotegut E Fluri G Orend 2008 Combined lysophosphatidic acid/platelet-derived growth factor signaling triggers glioma cell migration in a tenascin-C microenvironment Cancer Res 68 6942 6952 18757408
125. M Latijnhouwers M Bergers M Ponec H Dijkman M Andriessen J Schalkwijk 1997 Human epidermal keratinocytes are a source of tenascin-C during wound healing J Invest Dermatol. 108 776 783 9129232
126. MA Latijnhouwers M Bergers BH Van Bergen KI Spruijt MP Andriessen J Schalkwijk 1996 Tenascin expression during wound healing in human skin J Pathol. 178 30 35 8778312 (Pubitemid 26053394)
127. CS Lieber DG Weiss F Paronetto 2008 Value of fibrosis markers for staging liver fibrosis in patients with precirrhotic alcoholic liver disease Alcohol Clin Exp Res 32 1031 1039 18422837
128. VA Lightner F Gumkowski DD Bigner HP Erickson 1989 Tenascin/hexabrachion in human skin: biochemical identification and localization by light and electron microscopy J Cell Biol. 108 2483 2493 2472409
129. EY Lin JF Li L Gnatovskiy Y Deng L Zhu DA Grzesik H Qian XN Xue JW Pollard 2006 Macrophages regulate the angiogenic switch in a mouse model of breast cancer Cancer Res 66 11238 11246 17114237
130. WW Lin M Karin 2007 A cytokine-mediated link between innate immunity, inflammation, and cancer J Clin Invest. 117 1175 1183 17476347
131. AV Ljubimov M Saghizadeh KS Spirin HL Khin SL Lewin L Zardi MA Bourdon MC Kenney 1998 Expression of tenascin-C splice variants in normal and bullous keratopathy human corneas Invest Ophthalmol Vis Sci 39 1135 1142 9620072 (Pubitemid 28247347)
132. JD Loike L Cao S Budhu S Hoffman SC Silverstein 2001 Blockade of alpha 5 beta 1 integrins reverses the inhibitory effect of tenascin on chemotaxis of human monocytes and polymorphonuclear leukocytes through three-dimensional gels of extracellular matrix proteins J Immunol. 166 7534 7542 11390508
133. Z Lokmic T Lammermann M Sixt S Cardell R Hallmann L Sorokin 2008 The extracellular matrix of the spleen as a potential organizer of immune cell compartments Semin Immunol 20 4 13 18243017
134. A Lundell AI Olin M Morgelin S al-Karadaghi A Aspberg DT Logan 2004 Structural basis for interactions between tenascins and lectican C-type lectin domains: evidence for a crosslinking role for tenascins Structure 12 1495 1506 15296743
135. JL Luo S Maeda LC Hsu H Yagita M Karin 2004 Inhibition of NF-kappaB in cancer cells converts inflammation- induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression Cancer Cell. 6 297 305 15380520
136. AD Luster R Alon UH von Andrian 2005 Immune cell migration in inflammation: present and future therapeutic targets Nat Immunol. 6 1182 1190 16369557
137. EJ Mackie W Halfter D Liverani 1988 Induction of tenascin in healing wounds J Cell Biol. 107 2757 2767 2462568
138. S Maier R Lutz L Gelman A Sarasa-Renedo S Schenk C Grashoff M Chiquet 2008 Tenascin-C induction by cyclic strain requires integrin-linked kinase Biochim Biophys Acta 1783 1150 1162 18269918
139. J Marlind M Kaspar E Trachsel R Sommavilla S Hindle C Bacci L Giovannoni D Neri 2008 Antibody-mediated delivery of interleukin-2 to the stroma of breast cancer strongly enhances the potency of chemotherapy Clin Cancer Res. 14 6515 6524 18927291
140. D Martin M Brown-Luedi R Chiquet-Ehrismann 2003 Tenascin-C signaling through induction of 14-3-3 tau J Cell Biol. 160 171 175 12527748
141. LS Marton JR Gulcher K Stefansson 1989 Binding of hexabrachions to heparin and DNA J Biol Chem. 264 13145 13149 2473987
142. J Marx 2008 Cancer biology. All in the stroma: cancer's Cosa Nostra Science 320 38 41 18388269
143. A Matsuda T Hirota M Akahoshi M Shimizu M Tamari A Miyatake A Takahashi K Nakashima N Takahashi K Obara N Yuyama S Doi Y Kamogawa T Enomoto K Ohshima T Tsunoda S Miyatake K Fujita M Kusakabe K Izuhara Y Nakamura J Hopkin T Shirakawa 2005 Coding SNP in tenascin-C Fn-III-D domain associates with adult asthma Hum Mol Genet 14 2779 2786 16115819
144. A Matsuda A Yoshiki Y Tagawa H Matsuda M Kusakabe 1999 Corneal wound healing in tenascin knockout mouse Invest Ophthalmol Vis Sci 40 1071 1080 10235540
145. SA McClain M Simon E Jones A Nandi JO Gailit MG Tonnesen D Newman RA Clark 1996 Mesenchymal cell activation is the rate-limiting step of granulation tissue induction Am J Pathol 149 1257 1270 8863674
146. B McMahon HC Kwaan 2008 The plasminogen activator system and cancer Pathophysiol Haemost Thromb. 36 184 194 19176991
147. ML Mercado A Nur-e-Kamal HY Liu SR Gross R Movahed S Meiners 2004 Neurite outgrowth by the alternatively spliced region of human tenascin-C is mediated by neuronal alpha7beta1 integrin J Neurosci. 24 238 247 14715956
148. M Michele A Faissner 2009 Tenascin-C stimulates contactin-dependent neurite outgrowth via activation of phospholipase C Mol Cell Neurosci 41 397 408 19394429
149. KS Midwood JE Schwarzbauer 2002 Tenascin-C modulates matrix contraction via focal adhesion kinase- and Rho-mediated signaling pathways Mol Biol Cell 13 3601 3613 12388760
150. KS Midwood LV Valenick HC Hsia JE Schwarzbauer 2004 Coregulation of fibronectin signaling and matrix contraction by tenascin-C and syndecan-4 Mol Biol Cell 15 5670 5677 15483051
151. KS Midwood LV Williams JE Schwarzbauer 2004 Tissue repair and the dynamics of the extracellular matrix Int J Biochem Cell Biol 36 1031 1037 15094118
152. K Midwood S Sacre AM Piccinini J Inglis A Trebaul E Chan S Drexler N Sofat M Kashiwagi G Orend F Brennan B Foxwell 2009 Tenascin-C is an endogenous activator of toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease Nat Med 15 774 780 19561617
153. AJ Mighell J Thompson WJ Hume AF Markham PA Robinson 1997 Human tenascin-C: identification of a novel type III repeat in oral cancer and of novel splice variants in normal, malignant and reactive oral mucosae Int J Cancer 72 236 240 9219826
154. H Milting P Ellinghaus M Seewald H Cakar B Bohms A Kassner R Korfer M Klein T Krahn L Kruska A El Banayosy F Kramer 2008 Plasma biomarkers of myocardial fibrosis and remodeling in terminal heart failure patients supported by mechanical circulatory support devices J Heart Lung Transplant. 27 589 596 18503956
155. S Moritz S Lehmann A Faissner A von Holst 2008 An induction gene trap screen in neural stem cells reveals an instructive function of the niche and identifies the splicing regulator sam68 as a tenascin-C-regulated target gene Stem Cells. 26 2321 2331 18617690
156. JE Murphy-Ullrich VA Lightner I Aukhil YZ Yan HP Erickson M Hook 1991 Focal adhesion integrity is downregulated by the alternatively spliced domain of human tenascin J Cell Biol. 115 1127 1136 1720121
157. H Nakahara EC Gabazza H Fujimoto Y Nishii CN D'Alessandro-Gabazza NE Bruno T Takagi T Hayashi J Maruyama K Maruyama K Imanaka-Yoshida K Suzuki T Yoshida Y Adachi O Taguchi 2006 Deficiency of tenascin C attenuates allergen-induced bronchial asthma in the mouse Eur J Immunol 36 3334 3345 17125141
158. N Nakao N Hiraiwa A Yoshiki F Ike M Kusakabe 1998 Tenascin-C promotes healing of Habu-snake venom-induced glomerulonephritis: studies in knockout congenic mice and in culture Am J Pathol 152 1237 1245 9588892
159. M Nomi H Miyake Y Sugita M Fujisawa S Soker 2006 Role of growth factors and endothelial cells in therapeutic angiogenesis and tissue engineering Curr Stem Cell Res Ther. 1 333 343 18220878
160. G Orend 2005 Potential oncogenic action of tenascin-C in tumorigenesis Int J Biochem Cell Biol 37 1066 1083 15743679
161. G Orend R Chiquet-Ehrismann 2000 Adhesion modulation by antiadhesive molecules of the extracellular matrix Exp Cell Res 261 104 110 11082280
162. G Orend R Chiquet-Ehrismann 2006 Tenascin-C induced signaling in cancer Cancer Lett 244 143 163 16632194
163. G Orend W Huang MA Olayioye NE Hynes R Chiquet-Ehrismann 2003 Tenascin-C blocks cell-cycle progression of anchorage-dependent fibroblasts on fibronectin through inhibition of syndecan-4 Oncogene. 22 3917 3926 12813465
164. T Paallysaho K Tervo T Kivela I Virtanen A Tarkkanen T Tervo 1993 Cellular fibronectin and tenascin in an orbital nylon prosthesis removed because of infection caused by Staphylococcus aureus Graefes Arch Clin Exp Ophthalmol 231 61 65 7680328
165. M Paez-Ribes E Allen J Hudock T Takeda H Okuyama F Vinals M Inoue G Bergers D Hanahan O Casanovas 2009 Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis Cancer Cell. 15 220 231 19249680
166. DC Paik C Fu J Bhattacharya MD Tilson 2004 Ongoing angiogenesis in blood vessels of the abdominal aortic aneurysm Exp Mol Med. 36 524 533 15665585
167. OE Paivaniemi PK Maasilta HS Alho TL Vainikka US Salminen 2008 Epithelial tenascin predicts obliterative airway disease J Heart Lung Transplant. 27 400 407 18374876
168. K Parekh S Ramachandran J Cooper D Bigner A Patterson T Mohanakumar 2005 Tenascin-C, over expressed in lung cancer down regulates effector functions of tumor infiltrating lymphocytes Lung Cancer. 47 17 29 15603851
169. J Pas E Wyszko K Rolle L Rychlewski S Nowak R Zukiel J Barciszewski 2006 Analysis of structure and function of tenascin-C Int J Biochem Cell Biol 38 1594 1602 16698307
170. N Pendas-Franco O Aguilera F Pereira JM Gonzalez-Sancho A Munoz 2008 Vitamin D and Wnt/beta-catenin pathway in colon cancer: role and regulation of DICKKOPF genes Anticancer Res 28 2613 2623 19035286
171. GR Phillips LA Krushel KL Crossin 1998 Domains of tenascin involved in glioma migration J Cell Sci. 111 Pt 8 1095 1104 9512505
172. GP Pidgeon JH Harmey E Kay M Da Costa HP Redmond DJ Bouchier-Hayes 1999 The role of endotoxin/lipopolysaccharide in surgically induced tumour growth in a murine model of metastatic disease Br J Cancer 81 1311 1317 10604727
173. JW Pollard 2008 Macrophages define the invasive microenvironment in breast cancer J Leukoc Biol. 84 623 630 18467655
174. K Polyak RA Weinberg 2009 Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits Nat Rev Cancer. 9 265 273 19262571
175. AL Prieto C Andersson-Fisone KL Crossin 1992 Characterization of multiple adhesive and counteradhesive domains in the extracellular matrix protein cytotactin J Cell Biol. 119 663 678 1383239
176. AL Prieto GM Edelman KL Crossin 1993 Multiple integrins mediate cell attachment to cytotactin/tenascin Proc Natl Acad Sci U S A. 90 10154 10158 7694284
177. R Probstmeier P Pesheva 1999 Tenascin-C inhibits beta1 integrin-dependent cell adhesion and neurite outgrowth on fibronectin by a disialoganglioside- mediated signaling mechanism Glycobiology. 9 101 114 9949188
178. MD Puente Navazo D Valmori C Ruegg 2001 The alternatively spliced domain TnFnIII A1A2 of the extracellular matrix protein tenascin-C suppresses activation-induced T lymphocyte proliferation and cytokine production J Immunol. 167 6431 6440 11714809
179. DM Ramos B Chen J Regezi L Zardi R Pytela 1998 Tenascin-C matrix assembly in oral squamous cell carcinoma Int J Cancer 75 680 687 9495234
180. DA Reardon MR Zalutsky G Akabani RE Coleman AH Friedman JE Herndon 2nd RE McLendon CN Pegram JA Quinn JN Rich JJ Vredenburgh A Desjardins S Guruangan S Boulton RH Raynor JM Dowell TZ Wong XG Zhao HS Friedman DD Bigner 2008 A pilot study: 131I-antitenascin monoclonal antibody 81c6 to deliver a 44-Gy resection cavity boost Neuro Oncol. 10 182 189 18287339
181. Richter P, Tost M, Franz M, Altendorf-Hofmann A, Junker K, Borsi L, Neri D, Kosmehl H, Wunderlich H, Berndt A (2009) B and C domain containing tenascin-C: urinary markers for invasiveness of urothelial carcinoma of the urinary bladder? J Cancer Res Clin Oncol 135:1351-1358
182. S Riedl A Tandara M Reinshagen U Hinz A Faissner H Bodenmuller HJ Buhr C Herfarth P Moller 2001 Serum tenascin-C is an indicator of inflammatory bowel disease activity Int J Colorectal Dis 16 285 291 11686525
183. GP Riley RL Harrall TE Cawston BL Hazleman EJ Mackie 1996 Tenascin-C and human tendon degeneration Am J Pathol 149 933 943 8780397
184. JF Riou DL Shi M Chiquet JC Boucaut 1990 Exogenous tenascin inhibits mesodermal cell migration during amphibian gastrulation Dev Biol 137 305 317 1689260
185. CR Ruegg R Chiquet-Ehrismann SS Alkan 1989 Tenascin, an extracellular matrix protein, exerts immunomodulatory activities Proc Natl Acad Sci U S A. 86 7437 7441 2477841
186. C Ruiz W Huang ME Hegi K Lange MF Hamou E Fluri EJ Oakeley R Chiquet-Ehrismann G Orend 2004 Growth promoting signaling by tenascin-C [corrected] Cancer Res 64 7377 7385 15492259
187. JN Rybak C Roesli M Kaspar A Villa D Neri 2007 The extra-domain A of fibronectin is a vascular marker of solid tumors and metastases Cancer Res 67 10948 10957 18006840
188. C Sahlberg I Aukhil I Thesleff 2001 Tenascin-C in developing mouse teeth: expression of splice variants and stimulation by TGFbeta and FGF Eur J Oral Sci 109 114 124 11347655
189. Y Saito H Imazeki S Miura T Yoshimura H Okutsu Y Harada T Ohwaki O Nagao S Kamiya R Hayashi H Kodama H Handa T Yoshida F Fukai 2007 A peptide derived from tenascin-C induces beta1 integrin activation through syndecan-4 J Biol Chem. 282 34929 34937 17901052
190. Y Sawada K Onoda K Imanaka-Yoshida J Maruyama K Yamamoto T Yoshida H Shimpo 2007 Tenascin-C synthesized in both donor grafts and recipients accelerates artery graft stenosis Cardiovasc Res 74 366 376 17383619
191. L Schaefer A Babelova E Kiss HJ Hausser M Baliova M Krzyzankova G Marsche MF Young D Mihalik M Gotte E Malle RM Schaefer HJ Grone 2005 The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages J Clin Invest. 115 2223 2233 16025156
192. M Schafer S Werner 2008 Cancer as an overhealing wound: an old hypothesis revisited Nat Rev Mol Cell Biol. 9 628 638 18628784
193. J Schalkwijk PM Steijlen IM van Vlijmen-Willems B Oosterling EJ Mackie AA Verstraeten 1991 Tenascin expression in human dermis is related to epidermal proliferation Am J Pathol 139 1143 1150 1719820
194. J Schalkwijk I Van Vlijmen B Oosterling C Perret R Koopman J Van den Born EJ Mackie 1991 Tenascin expression in hyperproliferative skin diseases Br J Dermatol 124 13 20 1704250
195. S Schenk L Bruckner-Tuderman R Chiquet-Ehrismann 1995 Dermo-epidermal separation is associated with induced tenascin expression in human skin Br J Dermatol 133 13 22 7545419
196. S Schenk R Chiquet-Ehrismann EJ Battegay 1999 The fibrinogen globe of tenascin-C promotes basic fibroblast growth factor-induced endothelial cell elongation Mol Biol Cell 10 2933 2943 10473637
197. G Schmidinger G Hanselmayer S Pieh B Lackner S Kaminski I Ruhswurm C Skorpik 2003 Effect of tenascin and fibronectin on the migration of human corneal fibroblasts J Cataract Refract Surg. 29 354 360 12648649
198. LM Schnapp N Hatch DM Ramos IV Klimanskaya D Sheppard R Pytela 1995 The human integrin alpha 8 beta 1 functions as a receptor for tenascin, fibronectin, and vitronectin J Biol Chem. 270 23196 23202 7559467
199. M Seiffert SC Beck F Schermutzki CA Muller HP Erickson G Klein 1998 Mitogenic and adhesive effects of tenascin-C on human hematopoietic cells are mediated by various functional domains Matrix Biol 17 47 63 9628252
200. S Seite A Colige P Piquemal-Vivenot C Montastier A Fourtanier C Lapiere B Nusgens 2000 A full-UV spectrum absorbing daily use cream protects human skin against biological changes occurring in photoaging Photodermatol Photoimmunol Photomed 16 147 155 11019938
201. MM Seyger JP van Pelt J van den Born MA Latijnhouwers EM de Jong 1997 Epicutaneous application of leukotriene B4 induces patterns of tenascin and a heparan sulfate proteoglycan epitope that are typical for psoriatic lesions Arch Dermatol Res 289 331 336 9209678
202. E Shacter SA Weitzman 2002 Chronic inflammation and cancer Oncology (Williston Park) 16 217 226 229; discussion 230-2
203. M Silacci SS Brack N Spath A Buck S Hillinger S Arni W Weder L Zardi D Neri 2006 Human monoclonal antibodies to domain C of tenascin-C selectively target solid tumors in vivo Protein Eng Des Sel. 19 471 478 16928692
204. A Siri V Knauper N Veirana F Caocci G Murphy L Zardi 1995 Different susceptibility of small and large human tenascin-C isoforms to degradation by matrix metalloproteinases J Biol Chem. 270 8650 8654 7536739
205. B Sivasankaran M Degen A Ghaffari ME Hegi MF Hamou MC Ionescu C Zweifel M Tolnay M Wasner S Mergenthaler AR Miserez R Kiss MM Lino A Merlo R Chiquet-Ehrismann JL Boulay 2009 Tenascin-C is a novel RBPJkappa-induced target gene for Notch signaling in gliomas Cancer Res 69 458 465 19147558
206. MJ Smyth E Cretney MH Kershaw Y Hayakawa 2004 Cytokines in cancer immunity and immunotherapy Immunol Rev 202 275 293 15546400
207. J Spring K Beck R Chiquet-Ehrismann 1989 Two contrary functions of tenascin: dissection of the active sites by recombinant tenascin fragments Cell 59 325 334 2478295
208. P Sriramarao MA Bourdon 1993 A novel tenascin type III repeat is part of a complex of tenascin mRNA alternative splices Nucleic Acids Res 21 163 168 7680113
209. C Stockmann A Doedens A Weidemann N Zhang N Takeda JI Greenberg DA Cheresh RS Johnson 2008 Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis Nature 456 814 818 18997773
210. CS Swindle KT Tran TD Johnson P Banerjee AM Mayes L Griffith A Wells 2001 Epidermal growth factor (EGF)-like repeats of human tenascin-C as ligands for EGF receptor J Cell Biol. 154 459 468 11470832
211. JF Talts G Wirl M Dictor WJ Muller R Fassler 1999 Tenascin-C modulates tumor stroma and monocyte/macrophage recruitment but not tumor growth or metastasis in a mouse strain with spontaneous mammary cancer J Cell Sci. 112 1855 1864 10341205
212. M Tamaoki K Imanaka-Yoshida K Yokoyama T Nishioka H Inada M Hiroe T Sakakura T Yoshida 2005 Tenascin-C regulates recruitment of myofibroblasts during tissue repair after myocardial injury Am J Pathol 167 71 80 15972953
213. K Tanaka N Hiraiwa H Hashimoto Y Yamazaki M Kusakabe 2004 Tenascin-C regulates angiogenesis in tumor through the regulation of vascular endothelial growth factor expression Int J Cancer 108 31 40 14618612
214. SF Tavazoie C Alarcon T Oskarsson D Padua Q Wang PD Bos WL Gerald J Massague 2008 Endogenous human microRNAs that suppress breast cancer metastasis Nature 451 147 152 18185580
215. HC Taylor VA Lightner WF Beyer Jr D McCaslin G Briscoe HP Erickson 1989 Biochemical and structural studies of tenascin/hexabrachion proteins J Cell Biochem. 41 71 90 2482292
216. O Tiitta T Wahlstrom J Paavonen A Linnala S Sharma VE Gould I Virtanen 1992 Enhanced tenascin expression in cervical and vulvar koilocytotic lesions Am J Pathol 141 907 913 1384340
217. KT Tran L Griffith A Wells 2004 Extracellular matrix signaling through growth factor receptors during wound healing Wound Repair Regen. 12 262 268 15225204
218. KT Tran P Lamb JS Deng 2005 Matrikines and matricryptins: Implications for cutaneous cancers and skin repair J Dermatol Sci. 40 11 20 15993569
219. A Trebaul EK Chan KS Midwood 2007 Regulation of fibroblast migration by tenascin-C Biochem Soc Trans 35 695 697 17635125
220. P Tremble R Chiquet-Ehrismann Z Werb 1994 The extracellular matrix ligands fibronectin and tenascin collaborate in regulating collagenase gene expression in fibroblasts Mol Biol Cell 5 439 453 7519905
221. Tsukada B, Terasaki F, Shimomura H, Otsuka K, Otsuka K, Katashima T, Fujita S, Imanaka-Yoshida K, Yoshida T, Hiroe M, Kitaura Y (2009). High prevalence of chronic myocarditis in dilated cardiomyopathy referred for left ventriculoplasty: expression of tenascin C as a possible marker for inflammation. Hum Pathol 40:1015-1022
222. RP Tucker 1998 Quantitative in situ localization of tenascin-C alternatively spliced transcripts in the avian optic tectum Mol Vis. 4 18 9756954
223. RP Tucker 2001 Abnormal neural crest cell migration after the in vivo knockdown of tenascin-C expression with morpholino antisense oligonucleotides Dev Dyn 222 115 119 11507773
224. RP Tucker R Chiquet-Ehrismann 2009 The regulation of tenascin expression by tissue microenvironments Biochim Biophys Acta 1793 888 892 19162090
225. CJ van der Vleuten CG Snijders EM de Jong PC van de Kerkhof 1996 Effects of calcipotriol and clobetasol-17-propionate on UVB-irradiated human skin: an immunohistochemical study Skin Pharmacol 9 355 365 9055356
226. P Van Eyken R Sciot VJ Desmet 1990 Expression of the novel extracellular matrix component tenascin in normal and diseased human liver. An immunohistochemical study J Hepatol. 11 43 52 1697872
227. ME Villani B Morgun P Brunetti C Marusic R Lombardi I Pisoni C Bacci A Desiderio E Benvenuto M Donini 2009 Plant pharming of a full-sized, tumour-targeting antibody using different expression strategies Plant Biotechnol J 7 59 72 18793269
228. G Vollmer 1997 Biologic and oncologic implications of tenascin-C/hexabrachion proteins Crit Rev Oncol Hematol 25 187 210 9177941
229. T von Lukowicz M Silacci MT Wyss E Trachsel C Lohmann A Buck TF Luscher D Neri CM Matter 2007 Human antibody against C domain of tenascin-C visualizes murine atherosclerotic plaques ex vivo J Nucl Med. 48 582 587
230. S Vosseler N Mirancea P Bohlen MM Mueller NE Fusenig 2005 Angiogenesis inhibition by vascular endothelial growth factor receptor-2 blockade reduces stromal matrix metalloproteinase expression, normalizes stromal tissue, and reverts epithelial tumor phenotype in surface heterotransplants Cancer Res 65 1294 1305 15735015
231. K Wallner C Li PK Shah KJ Wu SM Schwartz BG Sharifi 2004 EGF-Like domain of tenascin-C is proapoptotic for cultured smooth muscle cells Arterioscler Thromb Vasc Biol 24 1416 1421 15178565
232. K Watanabe H Takahashi Y Habu N Kamiya-Kubushiro S Kamiya H Nakamura H Yajima T Ishii T Katayama K Miyazaki F Fukai 2000 Interaction with heparin and matrix metalloproteinase 2 cleavage expose a cryptic anti-adhesive site of fibronectin Biochemistry. 39 7138 7144 10852711
233. MB Wenk KS Midwood JE Schwarzbauer 2000 Tenascin-C suppresses Rho activation [see comments] J Cell Biol. 150 913 920 10953015
234. DJ Whitby MT Longaker MR Harrison NS Adzick MW Ferguson 1991 Rapid epithelialisation of fetal wounds is associated with the early deposition of tenascin J Cell Sci. 99 Pt 3 583 586 1719005
235. SA Williams JE Schwarzbauer 2009 A shared mechanism of adhesion modulation for tenascin-C and fibulin-1 Mol Biol Cell 20 1141 1149 19109427
236. DG Woodside DK Wooten BW McIntyre 1998 Adenosine diphosphate (ADP)-ribosylation of the guanosine triphosphatase (GTPase) rho in resting peripheral blood human T lymphocytes results in pseudopodial extension and the inhibition of T cell activation J Exp Med. 188 1211 1221 9763600
237. S Yamada T Ichida Y Matsuda Y Miyazaki T Hatano K Hata H Asakura N Hirota A Geerts E Wisse 1992 Tenascin expression in human chronic liver disease and in hepatocellular carcinoma Liver. 12 10 16 1373463
238. K Yamamoto K Onoda Y Sawada K Fujinaga K Imanaka-Yoshida H Shimpo T Yoshida I Yada 2005 Tenascin-C is an essential factor for neointimal hyperplasia after aortotomy in mice Cardiovasc Res 65 737 742 15664401
239. K Yamamoto K Onoda Y Sawada K Fujinaga K Imanaka-Yoshida T Yoshida H Shimpo 2007 Locally applied cilostazol suppresses neointimal hyperplasia and medial thickening in a vein graft model Ann Thorac Cardiovasc Surg. 13 322 330 17954989
240. Y Yokosaki H Monis J Chen D Sheppard 1996 Differential effects of the integrins alpha9beta1, alphavbeta3, and alphavbeta6 on cell proliferative responses to tenascin Roles of the beta subunit extracellular and cytoplasmic domains. J Biol Chem. 271 24144 24150 8798654
241. K Yokoyama HP Erickson Y Ikeda Y Takada 2000 Identification of amino acid sequences in fibrinogen gamma -chain and tenascin C C-terminal domains critical for binding to integrin alpha vbeta 3 J Biol Chem. 275 16891 16898 10747940
242. D Zagzag V Capo 2002 Angiogenesis in the central nervous system: a role for vascular endothelial growth factor/vascular permeability factor and tenascin-C. Common molecular effectors in cerebral neoplastic and non-neoplastic "angiogenic diseases" Histol Histopathol 17 301 321 11813879
243. Y Zhao SL Young 1995 TGF-beta regulates expression of tenascin alternative-splicing isoforms in fetal rat lung Am J Physiol 268 L173 L180 7532367
244. R Zukiel S Nowak E Wyszko K Rolle I Gawronska MZ Barciszewska J Barciszewski 2006 Suppression of human brain tumor with interference RNA specific for tenascin-C Cancer Biol Ther. 5 1002 1007 16775434